However, some limitations related to use of TMZ such as the over expression of O6-methylguanine-DNA methyltransferase (MGMT) and/or lacking of a DNA repair pathway in GBM cells (Hegi et al., 2005) still need to be addressed; therefore, effective recurrence needs to be explored further. This evidence concerns the gene MGMT and glioblastoma.